NASDAQ NMS - GLOBAL MARKET · KMDA
-1.09% · -$0.0800 · Vol 79.5K
Live · updated 15:08:44 ET
Kamada Ltd

Kamada Ltd

Biotechnology
$7.26
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
KMDA
Kamada Ltd
Tue Aug 4 · last completed session · daily score · 20h old
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

60/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Tue Aug 4 · last completed session · daily score · 20h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is KMDA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KMDA catalysts
About Kamada Ltd
Biotechnology
Listed since
2013
Employees
462
Country
IL

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.25
Day high
$7.33
Day low
$7.17
Previous close
$7.34
52W high
$9.31
-22.02% from high
52W low
$6.60
24% of range
Market cap
$423.5M
P/E
20.76×
EPS
$0.3476
Beta
0.96
Shares out
57.7M
Volume
79.5K
2.18× rel vol
Avg volume
36.4K
VWAP
$7.25
Price history computed in-house
1W
+3.57%
1M
-3.07%
3M
-12.11%
1Y
+5.99%
YTD
+2.83%
SMA 50 $7.31 · below
SMA 200 $7.72 · below
52W position 24%

KMDA overview

Veridion Score
60
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KMDA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KMDA Form 4 filings
Public disclosures

Congress activity in KMDA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for KMDA in the cached public ledger.

Federal contracts

KMDA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KMDA in this window.
Lobbying spend

KMDA lobbying filings, year to date.

Registered lobbying filings matched to Kamada Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KMDA in this window.
Loading news for KMDA
Analyst ratings
Sovereign unlock shows live analyst consensus for KMDA.
Options
Sovereign unlock shows live options positioning for KMDA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.